2cureX has signed a distribution agreement with specialized diagnostic solutions leader Werfen, to distribute 2cureX products in SpainHow IndiTreat works
How IndiTreat predicts tumor resistance and sensitivity
IndiTreat uses thousands of patient-derived microtumors to evaluate the response of your patients’ tumors to drugs and drug combinations. These include drugs recommended by guidelines and as a special request, we can test off label. We are able to recommend drugs as well as drug combinations. Drug combinations are of particular significance to IndiTreat, as IndiTreat is today the only practical means to test the effect of different combinations.
Measurement of drug resistance and sensitivity
![](https://www.2curex.com/wp-content/uploads/measurement_of_drug_resistance_and_sensitivity.jpg")
Want to know more?
Contact us
Please contact 2cureX for more information
Email: info@2cureX.com
Phone: +45 22115399
Web: www.IndiTreat.com
Upcoming events
December 7, 2021
CEO Fernando Andreu will present at ”Sedermeradagen Köbenhamn 2021” (Copenhagen, Denmark)
December 9, 2021
2cureX presents at HC Andersen Capital’s Virtual Growth Days (Copenhagen, Denmark)
January 20, 2022
2cureX present at Redeye Theme – Fight Cancer Seminar – Outlook 2022 (Stockholm, Sweden)
